Thursday, 12 April 2018

Cruelty-Free - Addressing animal Growth and Restrain Factors Analysis By 2022


Summary 
Growing awareness of social issues driven by consumer education and media coverage is leading to a rise in ethical consumerism. In recognizing the issue of animal cruelty, a portion of these ethical consumers seek to purchase only from brands that pertain to high animal welfare standards.
Scope of The Report
- Over two thirds of consumers find living an ethical and sustainable lifestyle important or very important in creating a feeling of wellbeing or wellness.
- Over a third of consumers who think that living an ethical or sustainable lifestyle is important in creating a feeling of wellbeing or wellness, say that they would consider buying products that support the humane treatment of animals.
- Over a third of consumers look for on-pack ethical/sustainability logos most of the time or all of the time.
Reasons to buy
- Gain insight into the different routes through by which products can align with the Cruelty-Free trend including examples of best-in-class innovation.
- Compare the presence of this trend in each industry across the FMCG space, and learn what the key opportunities are.
- Identify the innovation implications of the Cruelty-Free trend for your sector.

  Table of Contents 
Table of Contents
Trend snapshot
What is Cruelty-Free?
Why is Cruelty-Free important?
Who is driving Cruelty-Free?
How can be Cruelty-Free capitalized on?
What next in Cruelty-Free?
Appendix

  
  .Continued
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Dairy & Soy Food Sector Segmentation Detailed Study with Forecast Up To 2021


Urinary Catheters Diagnosis, treatments and Global Key players 2017


Summary 
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urinary Catheters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by team of industry experts.
Scope of The Report
- Extensive coverage of the Urinary Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Urinary Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry


  Table of Contents 
1 Table of Contents
1 Table of Contents 2
    1.1 List of Tables 6
    1.2 List of Figures 7
2 Introduction 8
    2.1 Urinary Catheters Overview 8
3 Products under Development 9
    3.1 Urinary Catheters - Pipeline Products by Stage of Development 9
    3.2 Urinary Catheters - Pipeline Products by Segment 10
    3.3 Urinary Catheters - Pipeline Products by Territory 11
    3.4 Urinary Catheters - Pipeline Products by Regulatory Path 12
    3.5 Urinary Catheters - Pipeline Products by Estimated Approval Date 13
4 Urinary Catheters - Pipeline Products under Development by Companies 14
    4.1 Urinary Catheters Companies - Pipeline Products by Stage of Development 14
    4.2 Urinary Catheters - Pipeline Products by Stage of Development 15
5 Urinary Catheters Companies and Product Overview 16
    5.1 Applied Catheter Technologies Inc. Company Overview 16
      5.1.1 Applied Catheter Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 16  
  .Continued
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Chicken Pox Global Market by Treatments, Causes, Drugs and Diet 2017-2022

Chicken Pox
Summary 
Clinical trial report, “Chicken Pox Global Clinical Trials Review, H1, 2017" provides an overview of Chicken Pox clinical trials scenario. This report provides top line data relating to the clinical trials on Chicken Pox. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1579700-chicken-pox-global-clinical-trials-review-h1-2017
Scope of The Report
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months


  Table of Contents 
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Chicken Pox to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Chicken Pox to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
  .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1579700-chicken-pox-global-clinical-trials-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

ICT Investment Trends in Germany - Granular Market Report and Review, 2017

ICT Investment Trends in Germany
Summary 
German enterprises are investing in various ICT domains in order to introduce pioneering digital services in the future. Germany's economy is growing firmly in 2017, and had a huge trade surplus in 2016, with high exports in vehicles, machinery, pharmaceuticals, and electrical equipment, which are pushing investments in the ICT sector. Software as a service (SaaS) was the most popular cloud computing solution in 2016, infrastructure as a service (IaaS) is also set to gain momentum in the next two years, driven by the need to achieve flexibility and scalability in their architecture for creating an on-demand infrastructure extension or scaling down without difficulty.

Click here for sample report @ http://www.wiseguyreports.com/sample-request/1579654-ict-investment-trends-in-germany-maintaining-data-privacy-and-security-is
Scope of The Report
- The survey shows that German enterprises are looking to increase their total ICT budget in 2017, indicating that enterprises are moving towards technology driven work environments to boost productivity.
- As the German government is focussing on helping small and medium-sized enterprises (SMEs) to digitally transform their businesses under its ‘Digital Strategy 2025’ plan, local software vendors and network providers are expected to attract greater opportunities in the SME market.
- Increasing customer satisfaction tops the list of business objectives, followed by the need to gain a competitive advantage, in influencing IT investment strategies among German enterprises.


  Table of Contents 
Table of Contents
Key findings
Key implications for ICT vendors
Executive summary
Survey demographics
ICT budget changes
ICT budget allocation by core technology area
Hardware budget breakdown
Software budget breakdown
Third party IT services expenditure
Communications expenditure
Cloud computing budget
ICT budget allocation by function
Outsourced IT functions
ICT investment priorities and vendor satisfaction
Enterprise applications
Internet of Things (IoT)
Cloud computing
Business intelligence
Business objectives influencing IT investment strategy
ICT provider selection
Key decision makers for purchasing technology
Appendix
  .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1579654-ict-investment-trends-in-germany-maintaining-data-privacy-and-security-is
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

The Baby Food Market - Granular Market Report and Review, H1 2017

The Baby Food Market
Summary 
The Chinese market for baby food rose by 23% between 2010 and 2016 in terms volume, but fell for the first time in recent years in 2016. Although the market is still underdeveloped, it has benefited from greater consumer spending power, the rising levels of urbanization and increased numbers of working women. Consumption increased in all sectors except drinks, although in value terms baby milks made the greatest gains, rising by 79% between 2010 and 2016. Baby milks continue to dominate the market, accounting for over 92% of value and 86% of volume sales. Much of the remainder is made up of cereals & dry meals, wet meals claim 2-3% of value sales, with finger foods and drinks together taking less than 1% of value sales. In coming years, once regulatory changes have concluded - sales are expected to be boosted by the expansion of distribution and by rising incomes. The overall market is forecast to increase by 26% in volume and 51% in value between 2016 and 2022.

Click here for sample report @ http://www.wiseguyreports.com/sample-request/1579596-the-baby-food-market-in-china-2017
Scope of The Report
- Consumption of baby food in China rose by 23% since 2010 in terms of volume. Market value rose by 78% between 2010 and 2016.
- The bulk of baby food sales continue to occur in the major cities, although increasingly affluent consumers are emerging in second-, third-, and even fourth-tier cities, as well as the better-off parts of the rural community.
- The Chinese infant formula market is the world’s largest; now well ahead of both the US and the total market in Western Europe.
- The market is highly fragmented with a large number of foreign and local manufacturers active.
- The majority of milks are now imported, due to strong consumer preference for imported products, but most cereals, meals, and other products are produced locally.

  Table of Contents 
Table of Contents
Introduction
Background to the Market
Market Overview
Sector Analysis
Production and Trade
Company Profiles
Distribution
Economic Background
Prospects and Forecasts
Appendix
  .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1579596-the-baby-food-market-in-china-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Latest Study Offers Detailed Insights on Neurofibromatoses Type I H1 2017

Neurofibromatoses Type I
Summary 
Neurofibromatosis type 1 (NF1), also called von Recklinghausen's disease, is a rare genetic disorder characterized by the development of multiple noncancerous (benign) tumors of nerves and skin (neurofibromas). This is transmitted on chromosome 17 and is caused by mutation of the NF1 gene. Symptoms include liver enlargement, glioma, Lisch nodules and pheochromocytoma. Treatment includes pain medications, surgery, chemotherapy and radiation therapy.

Click here for sample report @ http://www.wiseguyreports.com/sample-request/1510560-neurofibromatoses-type-i-von-recklinghausen-s-disease-pipeline-review-h1-2017
Report Highlights
The  Pharmaceutical and Healthcare latest pipeline guide Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Neurofibromatoses Type I (Von Recklinghausen’s Disease) (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Neurofibromatoses Type I (Von Recklinghausen’s Disease) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neurofibromatoses Type I (Von Recklinghausen’s Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 1, 1 and 2 respectively. Similarly, the Universities portfolio in Discovery stages comprises 1 molecules, respectively.
  Table of Contents 
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Overview
Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Companies Involved in Therapeutics Development
Alexion Pharmaceuticals Inc
Array BioPharma Inc  .Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1510560-neurofibromatoses-type-i-von-recklinghausen-s-disease-pipeline-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)